Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response
A D Seidman, B S Reichman, J P Crown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1993
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
B S Reichman, A D Seidman, J P Crown, et al.
Psycho-Oncology
|
February 11, 2000
A pilot study of interpersonal psychotherapy by telephone with cancer patients and their partners
J M Donnelly, A B Kornblith, S Fleishman, et al.
Psychosomatic Medicine
|
November 1, 1992
An experimental analysis of classically conditioned nausea during cancer chemotherapy
D H Bovbjerg, W H Redd, P B Jacobsen, et al.
International Journal of Obesity (2005)
|
November 7, 2017
Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link
H Zahid, K Subbaramaiah, N M Iyengar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 24, 2011
Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays
E Brogi, C G Murphy, M L Johnson, et al.
Oncology
|
October 1, 1994
Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer
A D Seidman, L Norton, B S Reichman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2014
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
J Baselga, A Manikhas, J Cortés, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 2011
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
M N Fornier, P G Morris, A Abbruzzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1995
Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response
A D Seidman, B S Reichman, J P Crown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1993
Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
B S Reichman, A D Seidman, J P Crown, et al.
Psycho-Oncology
|
February 11, 2000
A pilot study of interpersonal psychotherapy by telephone with cancer patients and their partners
J M Donnelly, A B Kornblith, S Fleishman, et al.
Psychosomatic Medicine
|
November 1, 1992
An experimental analysis of classically conditioned nausea during cancer chemotherapy
D H Bovbjerg, W H Redd, P B Jacobsen, et al.
International Journal of Obesity (2005)
|
November 7, 2017
Leptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link
H Zahid, K Subbaramaiah, N M Iyengar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 24, 2011
Breast carcinoma with brain metastases: clinical analysis and immunoprofile on tissue microarrays
E Brogi, C G Murphy, M L Johnson, et al.
Oncology
|
October 1, 1994
Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer
A D Seidman, L Norton, B S Reichman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 10, 2014
Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
J Baselga, A Manikhas, J Cortés, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 17, 2011
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
M N Fornier, P G Morris, A Abbruzzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1996
Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer
J Baselga, D Tripathy, J Mendelsohn, et al.
Page
of 5